This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (71)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Paul L. Doering, MS; Ronald B. Stewart, MS

JAMA. 1978;239(9):843-846.

Abstract
. One hundred sixty-eight obstetrical patients' conditions were monitored prospectively throughout the prenatal, perinatal, and postpartum periods to obtain data on maternal drug consumption. In the prenatal period, all patients received at least two different drug products: 93.4% received five or more, while one patient reported taking 32 different products. The average number of drug products used in the prenatal period was 11.0. The mean perinatal exposure in patients undergoing vaginal delivery was 7.0. Analysis by therapeutic category was performed. Information gathered confirms the fact that pregnant women do take a large number of different types of medications, the consequences of which remain unknown.

(JAMA 239:843-846, 1978)

Author Affiliations
From the College of Pharmacy, University of Florida, Gainesville.

Footnotes
Reprint requests to University of Florida College of Pharmacy, Box J-4, JHMHC, Gainesville, FL 32610 (Mr Doering).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Clinical Management Guidelines for Obstetrician-Gynecologists Use of Psychiatric Medications During Pregnancy and Lactation
ACOG Practice Bulletin
Focus 2009;7:385-400.
ABSTRACT | FULL TEXT  

Can Postmarketing Surveillance Help to Effect Optimal Drug Therapy?
Strom and Melmon
JAMA 1979;242:2420-2423.
ABSTRACT